IP Verse

Graf Von Stosch competitive analysis

Latest publications and patents of Graf Von Stosch New

Explore the latest publications and patents granted to Graf Von Stosch, showcasing their recent innovations and technological advancements.

Latest oppositions filed by Graf Von Stosch

Explore patent oppositions filed by Graf Von Stosch against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Oct 2, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

EP3487881
Methods Of Treating New-Onset Plaque Type Psoriasis Using Il-17 AntagonistsNOVARTISMay 21, 2025
EP2854831
Manufacture Of DegarelixFERRINGApr 10, 2025
EP3529360
Methods For Preventing Cardiovascular Events Through Proprotein Convertase Subtilisin Kexin 9 (Pcsk9) Protein ReductionNOVARTISJan 17, 2025
EP3191120
Use Of Il-17 Antagonists To Inhibit The Progression Of Structural Damage In Psoriatic Arthritis PatientsNOVARTISJan 10, 2025
EP3328416
Use Of C-Type Natriuretic Peptide Variants To Treat Skeletal DysplasiaBIOMARIN PHARMACEUTICALDec 13, 2024
EP3334747
Charged Depth Filtration Of Antigen-Binding ProteinsAMGENJun 27, 2024
EP3373013
Method For Predicting The Off-Target Biding Of A Peptide Which Binds To A Target Peptide Presented By A Major Histocompatibility ComplexADAPTIMMUNEApr 18, 2024
EP3191517
Cross Reactive Siglec AntibodiesINNATE PHARMAAug 3, 2021
EP2911684
Il-15R Alpha Forms, Cells Expressing Il-15R Alpha Forms, And Therapeutic Uses Of Il-15R Alpha And Il-15/Il-15R Alpha ComplexesADMUNE THERAPEUTICSMar 19, 2020
EP2936158
Method For Predicting The Off-Target Biding Of A Peptide Which Binds To A Target Peptide Presented By A Major Histocompatibility ComplexADAPTIMMUNENov 12, 2019

Latest PTAB cases involving Graf Von Stosch

Discover the latest PTAB cases involving Graf Von Stosch, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Graf Von Stosch with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 2, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases FacedStrategy Type
GRAF VON STOSCH3 - - - Highly Aggressive
ADMUNE THERAPEUTICS - 2 - - Non-Active
INNATE PHARMA - 2 - - Non-Active
NOVARTIS6406 - 21Defensive